The phase of drug testing that determines the pharmacokinetics, toxicity, and safe dose in humans is:
a. Phase one
b. Phase two
c. Phase three
d. Phase four
a
Rationale: a. The primary purpose of phase one testing is to determine the pharmacokinetics, toxicity, and safe dose in humans.
b. Tthe primary purpose of phase ttwo testing is to find the therapeutic medication level and watch carefully for toxic and side effects.
c. The primary purpose of phase threeItesting is to refine the usual therapeutic dose and to collect relevant data on side effects.
d. The primary purpose of phase Ifour testing involves postmarketing analysis during conditional approval.
You might also like to view...
The recommended dose for atropine is 0.3mg/kg per dose. What would be the appropriate dose for a 220-pound patient?
A) 66mg B) 30mg C) 0.36mg D) 3mg
You have determined that your patient, a 6-year-old boy, most likely has epiglottitis. He has developed a high fever and appears very ill. You realize that this is a serious illness and you need to handle your patient carefully. You should:
A) not place anything in his mouth. B) give him ice chips to suck on. C) have him lie down with his head elevated. D) check his temperature regularly.
What type of solution could have 1 mol of solute per liter of solution?
a. Molal b. Molar c. Normal d. Weight/volume
What is dental plaque?
A) A silver plate used to straighten teeth B) Poor positioning of the teeth C) Holes or decayed portions of the tooth D) A mass of microorganisms that grows on the exposed portions of the teeth and may spread below the gingival line